Location History:
- Pohang-si, KR (2015 - 2016)
- Suwon-si, KR (2010 - 2020)
- Seongnam-si, KR (2013 - 2022)
- Seoul, KR (2019 - 2022)
Company Filing History:
9 out of 131,744 
4 out of 658 
3 out of 27,427 
Years Active: 2010-2022
Title: Jong In Kim: Pioneering Innovations in Biomolecule Imaging and Cancer Therapeutics
Introduction
Jong In Kim is an accomplished inventor based in Suwon-si, South Korea, known for his significant contributions to the fields of biomolecule imaging and cancer treatment. With an impressive portfolio of 18 patents, he continues to push the boundaries of medical technology through innovative solutions.
Latest Patents
Among his latest patents, the "Biomolecule imaging method using aptamer" stands out for its potential to revolutionize cancer diagnostics. This method utilizes a composition that includes a fluorescence- or radioactive isotope-labeled ERBB2 aptamer to visualize tumorous disease regions within the body. The aptamer, when hybridized with labeled oligonucleotides, enhances imaging capabilities in vivo, providing a promising avenue for early detection and treatment planning.
Another noteworthy patent is his "Aptamer-drug conjugate and use thereof," which reveals a targeted therapeutic agent designed for cancer treatment that features a drug-linker-AS1411 structure. The versatile composition allows for the use of various cytotoxic agents, including monomethyl auristatin E (MMAE), doxorubicin, and pyrrolobenzodiazepine (PBD), among others, thereby expanding the therapeutic options available for combating cancer.
Career Highlights
Jong In Kim has built a reputable career in advanced research and development, having worked with prominent organizations such as Samsung Electronics Co., Ltd., where he applied his engineering expertise to innovative projects. He was also associated with the Postech Academy–Industry Foundation, further collaborating on research initiatives aimed at merging academic insights with industry applications.
Collaborations
Kim's work is marked by effective collaborations with notable professionals in his field. He has worked alongside talented individuals like Jung Hwan Lee and Jong Hun Im, contributing to the progression of innovative ideas and solutions within the realm of biomolecular research and cancer therapy.
Conclusion
Jong In Kim stands as a beacon of innovation in the technology and healthcare sectors. His extensive patent portfolio reflects his dedication to advancing medical treatments and improving diagnostic methods. As he continues to explore new frontiers in his research, the impact of his work is likely to be felt in the lives of many, paving the way for significant advancements in how we approach cancer detection and treatment.